This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, X.
Right arrow Articles by Standiford, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, X.
Right arrow Articles by Standiford, T. J.

 Previous Article  |  Next Article 

Infection and Immunity, March 2003, p. 1306-1315, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1306-1315.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Intrapulmonary Expression of Macrophage Inflammatory Protein 1{alpha} (CCL3) Induces Neutrophil and NK Cell Accumulation and Stimulates Innate Immunity in Murine Bacterial Pneumonia

Xianying Zeng,1 Thomas A. Moore,1 Michael W. Newstead,1 Ruben Hernandez-Alcoceba,2 Wan C. Tsai,3 and Theodore J. Standiford1*

Department of Medicine, Division of Pulmonary and Critical Care Medicine,1 Division of Hematology/Oncology,2 Department of Pediatrics, The University of Michigan Medical School, Ann Arbor, Michigan 48109-03603

Received 7 August 2002/ Returned for modification 3 October 2002/ Accepted 29 November 2002

Macrophage inflammatory protein 1{alpha} (MIP-1{alpha}) (CCL3) is an important mediator of leukocyte recruitment and activation in a variety of inflammatory states, including infection. A recombinant human type 5 adenovirus containing the murine MIP-1{alpha} cDNA (AdMIP-1{alpha}) was constructed to determine the effect of transient intrapulmonary expression of MIP-1{alpha} on leukocyte recruitment, activation, and bacterial clearance in a murine model of Klebsiella pneumoniae pneumonia. The intratracheal administration of AdMIP-1{alpha} resulted in both time- and dose-dependent expression of MIP-1{alpha} mRNA and protein within the lung. Importantly, the intrapulmonary overexpression of MIP-1{alpha} resulted in a maximal 35- and 100-fold reduction in lung and blood bacterial burden, respectively, in animals cochallenged with K. pneumoniae, which was associated with a significant increase in neutrophil and activated NK cell accumulation. Furthermore, the transgenic expression of MIP-1{alpha} during bacterial pneumonia resulted in enhanced expression of gamma interferon mRNA, compared to that observed in Klebsiella-challenged animals pretreated with control vector. These findings indicate an important role for MIP-1{alpha} in the recruitment and activation of selected leukocyte populations in vivo and identify this cytokine as a potential immunoadjuvant to be employed in the setting of localized bacterial infection.


* Corresponding author. Mailing address: The University of Michigan Medical Center, Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, 6301 MSRBIII, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-0642. Phone: (734) 764-4554. Fax: (734) 764-4556. E-mail: tstandif{at}umich.edu.

Editor: D. L. Burns


Infection and Immunity, March 2003, p. 1306-1315, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1306-1315.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Bernardini, G., Sciume, G., Bosisio, D., Morrone, S., Sozzani, S., Santoni, A. (2008). CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood 111: 3626-3634 [Abstract] [Full Text]  
  • Sherry, B., Dai, W. W., Lesser, M. L., Trachtman, H. (2008). Dysregulated Chemokine Receptor Expression and Chemokine-Mediated Cell Trafficking in Pediatric Patients with ESRD. CJASN 3: 397-406 [Abstract] [Full Text]  
  • Renckens, R., Roelofs, J. J. T. H., Bonta, P. I., Florquin, S., de Vries, C. J. M., Levi, M., Carmeliet, P., van't Veer, C., van der Poll, T. (2007). Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 109: 1593-1601 [Abstract] [Full Text]  
  • Pelletier, M., Bouchard, A., Girard, D. (2004). In Vivo and In Vitro Roles of IL-21 in Inflammation. J. Immunol. 173: 7521-7530 [Abstract] [Full Text]